Cas:821-48-7 Bis(2-Chloroethyl)amine hydrochloride manufacturer & supplier

Chemical Name:Bis(2-Chloroethyl)amine hydrochloride

CAS.NO:821-48-7

Synonyms:2-Chlor-N-(2-chlorethyl)ethanaminhydrochlorid;MFCD00012515;2-Chloro-N-(2-chloroethyl)ethanamine hydrochloride (1:1);Bis(2-chloroethyl)amine Hydrochloride;EINECS 212-479-5;2-chloro-N-(2-chloroethyl)ethanamine hydrochloride;Ethanamine, 2-chloro-N- (2-chloroethyl)-, hydrochloride;Bis(β-chloroethyl)amine hydrochloride;Ethanamine, 2-chloro-N-(2-chloroethyl)-, hydrochloride (1:1);Bis(2-Chloroethyl)Amine HCL

Molecular Formula:C₄H₁₀Cl₃N

Molecular Weight:178.488

HS Code:29211980

Physical and Chemical Properties:

Melting point:212-214 °C(lit.)

Boiling point:204.2ºC at 760 mmHg

Density:1.125 g/cm3

Index of Refraction:

PSA:12.03000

Exact Mass:176.987885

LogP:2.24650

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:2811

Packing Group:III

Contact us for information like 2-Chlor-N-(2-chlorethyl)ethanaminhydrochlorid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Bis(2-Chloroethyl)Amine HCL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Bis(β-chloroethyl)amine hydrochloride Use and application,2-Chlor-N-(2-chlorethyl)ethanaminhydrochlorid technical grade,usp/ep/jp grade.

Related News: Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. Bis(2-Chloroethyl)amine hydrochloride manufacturer The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself. Bis(2-Chloroethyl)amine hydrochloride supplier The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself. Bis(2-Chloroethyl)amine hydrochloride vendor J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed. Bis(2-Chloroethyl)amine hydrochloride factory Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.